Maternal Vaccine Safety Surveillance Enters New Phase
New international efforts aim to strengthen safety monitoring for expectant families through integrated medical data.
Updated on Oct. 23, 2026 in Pregnancy
Live Poll
Do you trust that better data monitoring for maternal vaccines increases overall vaccine safety?
KEMRI and global partners are launching the second phase of a maternal vaccine safety surveillance program in Kenya and Ghana. This three-year initiative seeks to improve how pregnancy and newborn health outcomes are tracked through electronic medical systems.
Why it matters
Active surveillance provides essential data on maternal and infant health that informs future regulatory decisions. By integrating these tools into routine clinical practice, the program aims to monitor safety without adding to the administrative workload of local health providers.
The three-year Phase II program focuses on integrating surveillance into health systems across Kenya and Ghana. Researchers are currently evaluating methods to link pregnancy databases with medical records to ensure accurate data collection.
The players
KEMRI
The Kenya Medical Research Institute conducts health research and partners with global organizations to improve maternal and child health outcomes.
African Medicines Agency
A continental regulatory body that coordinates safety protocols and standards for medical products across African nations.
The details
The surveillance system is designed to embed safety reporting directly into existing clinical workflows to streamline data collection for medical staff. Researchers are exploring how to bridge gaps between pregnancy health records and electronic databases to track long-term maternal and newborn outcomes. The program also intends to launch a pilot study assessing the role of artificial intelligence in analyzing these consolidated medical datasets.
Timeline
October 14-16, 2026: Partners held the annual working meeting in Malindi to establish priorities.
The Home Front
The initiative marks a significant advancement in how health systems monitor vaccine safety for expectant families. It builds upon current global efforts to standardize maternal data collection to better inform public health outcomes.
Expectant parents in participating regions should understand that this program works in the background of clinical care to improve data safety. No action is required by households, as the system integrates directly into existing health information infrastructure.
The takeaway
The second phase of this surveillance program prioritizes the long-term safety of mothers and newborns through improved data integration. Families receiving care in these health systems can expect researchers to focus on digitizing health records to provide clearer safety profiles for immunization.
Further reading
For broader insights on health monitoring during the prenatal period, visit the Pregnancy section.
Source note: This article includes information reported by KEMRI.
Live Poll
Do you trust that better data monitoring for maternal vaccines increases overall vaccine safety?
